Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01414
|
|||||
Drug Name |
Beta-Carotene
|
|||||
Synonyms |
beta-carotene; 7235-40-7; beta Carotene; beta,beta-Carotene; Betacarotene; Provitamin A; Solatene; Carotaben; Provatene; all-trans-beta-Carotene; Serlabo; Natural Yellow 26; Karotin; KPMK; C.I. Food Orange 5; Solatene (caps); Karotin [Czech]; Food orange 5; Zlut prirodni 26; Betacarotenum [Latin]; Betacaroteno [Spanish]; Lucaratin; BetaVit; beta-Karotin; beta-Carotin; beta;-Carotene; beta-Carotene, all-trans-; .beta. Carotene; .beta.-Carotene; Betacarotenum [INN-Latin]; C.I. 75130; Betacaroteno [INN-Spanish]; Zlut prirodni 26 [Czech]
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Vitamin deficiency [ICD11: 5B55-5B7Z] | Approved | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C40H56
|
|||||
Canonical SMILES |
CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C)C)C
|
|||||
InChI |
InChI=1S/C40H56/c1-31(19-13-21-33(3)25-27-37-35(5)23-15-29-39(37,7)8)17-11-12-18-32(2)20-14-22-34(4)26-28-38-36(6)24-16-30-40(38,9)10/h11-14,17-22,25-28H,15-16,23-24,29-30H2,1-10H3/b12-11+,19-13+,20-14+,27-25+,28-26+,31-17+,32-18+,33-21+,34-22+
|
|||||
InChIKey |
OENHQHLEOONYIE-JLTXGRSLSA-N
|
|||||
CAS Number |
CAS 7235-40-7
|
|||||
Pharmaceutical Properties | Molecular Weight | 536.9 | Topological Polar Surface Area | 0 | ||
Heavy Atom Count | 40 | Rotatable Bond Count | 10 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 0 | |||
XLogP |
13.5
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:17579
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | beta-Carotene was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters. Phytomedicine. 2012 Aug 15;19(11):977-87. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.